Depressions in the elderly;Depresje u osób w wieku podeszłym

Psychogeriatria Polska

Volumn 4, Issue 1, 2007, Pages 51-60

  Dobrzyńska, Ewelina ^a   Rymaszewska, Joanna ^a   Kiejna, Andrzej ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Depression; Elderly; Etiology

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RALOXIFENE; RESERPINE; SIMVASTATIN; TAMOXIFEN; TOPIRAMATE; VIGABATRIN;

ARTICLE; DEMENTIA; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CONTROL; ELDERLY CARE; HUMAN; MINI MENTAL STATE EXAMINATION; PHYSICAL DISEASE; RISK ASSESSMENT; SUICIDE; SYMPTOM;

EID: 34547431726     PISSN: 17322642     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Krzyzanowski J. Psychogeriatria. Warszawa: Medyk; 2004.
2. Puzyński S. Depresje i zaburzenia afektywne. Warszawa: Wyd. Lek. PZWL; 2002.
3. Turczyński J, Bilikiewicz A. Depresja u osób w podeszłym wieku. Psychiatria w praktyce ogólnolekarskiej 2002; 2: 1.
4. Reynolds CF, Dew MA, Frank E i wsp. Effects of age at onset of first lifetime episode of recurrent major depression on treatment response and illness course in elderly patients. Am J Psychiatry 1998; 155(6): 795-799.
5. Harpole LH, Williams JW. Rozpoznawanie i leczenie depresji wieku podeszłego. Psychiatria po dyplomie 2005; 2(2): 23-28.
6. Pankiewicz P, Bielicka Z, Lamparska E. Specyfika leczenia depresji wieku podeszłego. Psychiatria Polska 2002; 6: 177-186.
7. Walker Z, Katona CLE. Depression in elderly people with physical illness. W: Robertson MM, Katona CLE (red.). Depression and physical illness. Perspectives in psychiatry vol. 6. Chichester: John Wiley& Sons;1997, s. 169-184.
8. Krishnan KRR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry 1997; 154: 497-500.
9. Bilikiewicz A, Matkowska-Białko D. Zaburzenia funkcji poznawczych a depresja. Udar mózgu 2004; 6(1): 27-37.
10. Alexopoulos GS, Meyers BS, Young RC, Kakurna T, Silbersweig D, Charlson M. Clinically defined vascular depression. Am J Psychiatry 1997; 154: 562-565.
11. Kotlyar M, Dysken M, Adson DE. Update on drug-induced depression in the elderly. Am J Geriatr Pharmacother 2005; 3(4): 288-300.
12. Carney RM, Rich MW, Freedland KE i wsp. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom. Med. 1988; 50: 627-633.
13. Lemieux G, Davingnon A, Genest J. Depressive states during Rauwolfia therapy for arterial hypertension: A report of 30 caces. Can Med Asoc J 1956; 74: 522-526.
14. Waal HJ. Propranolol-induced depression. BMJ 1967; 2: 50.
15. Ko DT, Herbert PR, Coffey CS i wsp. Beta-blocekr therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 2002; 288: 351-357.
16. Patten SB, Williams JV, Love EJ. Self-reported depressive symptoms following treatment with corticosteroids and sedative-hypnotics. Int J Psychiatry Med 1996; 26: 15-24.
17. Patten SB, Neutel CI. Corticosteroid-induced adverse psychiatric effects: Incidence, diagnosis and management. Drug Saf 2000; 22: 111-122.
18. Day R, Ganz PA, Costantino JP. Tamoxifen and depression: More evidence from the National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention (P-1) randomized study. J Natl Cancer Inst 2001; 93: 1615-1623.
19. Niceklsen T, Lufkin EG, Riggs BL i wsp. Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women. Psychoneuroendocrinology 1999; 24: 115-128.
20. Hyyppa MT, Kronholm E, Virtanen A i wsp. Does simvastatin affect mood and steroid hormone levels in hypercholestrolemic men? A randomized double-blind trial. Psychoneuroendocrinology 2003; 68: 355-358.
21. Levinson DF, Devinsky O. Psychiatric adverse events during vigabatrin therapy. Neurology 1999; 53: 1503-1511.
22. Wilding J, Van Gaal L, Rissanen A i wsp. A randomized double-blind placebo-controlled study of the long-term efficaacy and safety of topiramate in the treatment of obese subjects. Int J Obes Relat Metab Disord 2004; 28: 1399-1410.
23. Fick DM, Cooper JW, Wade WE i wsp. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716-2724.
24. Mackinnon NJ, Helper CD. Preventable drug-related morbidity in older adults. Indicator development. J Manag Care Pharm 2002; 8: 365-371.
25. Grabowska-Grzyb A, Jedrzejczak J, Nagańska E i wsp. Risk factor for depression in patients with epilepsy. Epilepsy & Behavior 2006; 8: 411-417.
26. Drayer RA, Mulsant BH, Lenze EJ, Rollman BL, Dew MA, Kelleher K, Karp JF, Begley A, Schulberg HC, Reynolds III ChF. Somatic symptoms of depression in elderly patients with medical comorbidities. Int J Ger Psychiatr 2005; 20: 973-982.
27. Saray K, Kirmayer LJ, Taillefer SS. Predictors of somatic symptoms in depressive disorder. Gen Hosp Psychiatry 2003; 25: 108-114.
28. Berardi D, Menchetti M, De Ronchi D i wsp. Ferrari G. Late-life depression In primary care: a nationwide Italia epidemiological survey. J Am Geriatr Soc 2002; 50(1): 77-83.
29. Green RC. Diagnosis and Managment of Alzheimer's Disease and Other Dementias. Caddo, OK: Professional Communications, Inc; 2005, s. 37.
30. Adler G, Chwalek K, Jajcevic. Six-month course of mild cognitive impairment and affective symptoms in late-life depression. Eur Psychiatry 2004; 19: 502-505.
31. Alexopoulos GS. Depression in the elderly. Lancer 2005; 365: 196-1970.
32. Borkowska A, Kałwa A, Ziółkowska-Kochan M, Rybakowski J. Badania neuropsychologiczne czynności kory przedczołowej w depresji powyżej 50. roku życia i w łagodnych zaburzeniach poznawczych. Postepy Psychiatrii i Neurologii 2006; 15(1): 1-6.
33. Lovestone S. Early diagnosis and treatment of Alzheimer's disease. London: Matin Dunitz; 1998, s. 17.
34. Diagnostic and Statistical Manual of Mental Disorders, wyd. IV. Washington DC: American Psychiatric Association; 1994.
35. Miedzynarodowa Statystyczna Klasyfikacja Chorób i Problemów Zdrowotnych. Rewizja dziesiata. Klasyfikacja zaburzeń psychicznych i zaburzeń zachowania w ICD-10. Kraków-Warszawa: UWM "Vesalius"; 2000.
36. Milwain EJ, Nagy Z. Depressive symptoms increase the likehood of cognitive impairment in elderly people with subclinical Alzheimer pathology. Dement Geriatr Cogn Disord 2005; 19: 46-50.
37. Kessing LV, Andersen PK. Does the risk of developing dementia increase with the number of episodes in patient 5with depressive disorder and in patients with bipolar disorder? J Neurol Neurosurg Psychiatry 2004; 7: 1662-1666.
38. Parnowski T. Komentarz. Harpole LH, Williams JW. Rozpoznawanie i leczenie depresji wieku podeszłego. Psychiatria po dyplomie 2005; 2(2): 23-28.
39. Pitt B. Psychogeriatria. Wprowadzenie do psychiatrii wieku podeszłego, wyd. II. Warszawa: PZWL; 1986.
40. Dennis M, Baillon S, Brugha T, Lindesay J, Stewart R, Meltzer H. The spectrum of suicidal ideation in Great Britain: comparisons across a 16-74 years age range. Psychol Med. 2007; 9: 1-11.
41. Conwell Y, Lyness JM, Duberstein P i wsp. Completed suicide among older patients in primary care practices: a controlled study. J Am Geriatr Soc 2000; 48: 23-29.
42. Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull 1988; 24: 709-710.
43. Alexopoulos GS, Abrams RC, Young RC i in. Cornell Scale for Depression in Dementia. Biol Psychiatry 1988; 23: 271-284.
44. Sunderland T Alterman IS, Yount D i in. A new scale for the assessment of depressed mood in demented patients. Am J Psychiatry 1988; 145: 955-959.